Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Enters into New $1.5B Credit Agreement

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Friday that it has entered into a new $1.5 billion credit agreement, replacing the existing $1 billion revolving credit agreement.

The new agreement is a five-year senior unsecured revolving facility, Thermo Fisher said in a document filed with the US Securities and Exchange Commission. Thermo Fisher entered into the new agreement on July 25.

Bank of America is the administrative agent and the swingline lender. Other lenders include Goldman Sachs Bank, JP Morgan, Morgan Stanley, and Barclay Banks, among others.

Proceeds of the credit extensions may go toward repayment of obligations under the prior credit agreement, as well as for working capital, acquisitions, share repurchases, and other general corporate uses.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.